The present invention relates to the field of pharmaceutical formulations ofantibodies. Specifically, the present invention relates to a stable liquidantibodyformulation comprising methionine and its pharmaceutical preparation. Thisinventionis exemplified by a liquid formulation of an anti-Tumor Necrosis Factor alpha(TNF.alpha.)antibody.